Development and external validation of a nomogram for predicting short-term prognosis in patients with acute pulmonary embolism

医学 列线图 肺栓塞 心脏病学 内科学 期限(时间) 重症监护医学 物理 量子力学
作者
Chaowei Ding,Chao Liu,Ziping Zhang,Chunyan Cheng,Guangsheng Pei,Zhi‐Cheng Jing,Jiayong Qiu
出处
期刊:International Journal of Cardiology [Elsevier BV]
卷期号:407: 132065-132065 被引量:2
标识
DOI:10.1016/j.ijcard.2024.132065
摘要

Background Accurate assessment and timely intervention play a crucial role in ameliorating poor short-term prognosis of acute pulmonary embolism (APE) patients. The currently employed scoring models exhibit a degree of complexity, and some models may not comprehensively incorporate relevant indicators, thereby imposing limitations on the evaluative efficacy. Our study aimed to construct and externally validate a nomogram that predicts 30-day all-cause mortality risk in APE patients. Methods Clinical data from APE patients in Intensive Care-IV database was included as a training cohort. Additionally, we utilized our hospital's APE database as an external validation cohort. The nomogram was developed, and its predictive ability was evaluated using receiver operating characteristic (ROC) curves, calibration plots and decision curve analysis. Results A collective of 1332 patients and 336 patients were respectively enrolled as the training cohort and the validation cohort in this study. Five variables including age, malignancy, oxygen saturation, blood glucose, and the use of vasopressor, were identified based on the results of the multivariate Cox regression model. The ROC value for the nomogram in the training cohort yielded 0.765, whereas in the validation group, it reached 0.907. Notably, these values surpassed the corresponding ROC values for the Pulmonary Embolism Severity Index, which were 0.713 in the training cohort and 0.754 in the validation cohort. Conclusions The nomogram including five indicators had a good performance in predicting short-term prognosis in patients with APE, which was easier to apply and provided better recommendations for clinical decision-making.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
十七完成签到 ,获得积分10
2秒前
Singularity应助科研通管家采纳,获得10
3秒前
大模型应助科研通管家采纳,获得10
3秒前
ccc应助科研通管家采纳,获得10
3秒前
麦当当应助科研通管家采纳,获得10
3秒前
凤迎雪飘应助科研通管家采纳,获得10
3秒前
热心路人应助科研通管家采纳,获得10
3秒前
3秒前
YingyingFan应助科研通管家采纳,获得10
3秒前
劲秉应助科研通管家采纳,获得10
3秒前
hao完成签到,获得积分10
3秒前
3秒前
科研通AI2S应助科研通管家采纳,获得10
3秒前
Singularity应助科研通管家采纳,获得10
3秒前
FashionBoy应助科研通管家采纳,获得10
3秒前
4秒前
Singularity应助科研通管家采纳,获得10
4秒前
Singularity应助科研通管家采纳,获得10
4秒前
科研通AI5应助科研通管家采纳,获得10
4秒前
36456657应助科研通管家采纳,获得10
4秒前
劲秉应助科研通管家采纳,获得10
4秒前
YingyingFan应助科研通管家采纳,获得10
4秒前
5秒前
ccc应助科研通管家采纳,获得10
5秒前
Singularity应助科研通管家采纳,获得10
5秒前
劲秉应助科研通管家采纳,获得10
5秒前
wbx完成签到,获得积分10
6秒前
unfeeling8完成签到 ,获得积分10
11秒前
朴素的紫安完成签到 ,获得积分10
13秒前
星辰完成签到,获得积分10
18秒前
tiger完成签到 ,获得积分10
19秒前
zhaoxiaonuan完成签到,获得积分10
19秒前
wangermazi完成签到,获得积分10
24秒前
火星上的念桃完成签到 ,获得积分10
26秒前
微笑的人形立牌完成签到,获得积分10
29秒前
RUC_Zhao完成签到,获得积分10
40秒前
gnr2000完成签到,获得积分10
43秒前
依霏完成签到,获得积分10
43秒前
公西翠萱完成签到,获得积分10
44秒前
大力的野狼完成签到,获得积分10
47秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Neuromuscular and Electrodiagnostic Medicine Board Review 1000
こんなに痛いのにどうして「なんでもない」と医者にいわれてしまうのでしょうか 510
いちばんやさしい生化学 500
Genre and Graduate-Level Research Writing 500
The First Nuclear Era: The Life and Times of a Technological Fixer 500
岡本唐貴自伝的回想画集 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3674546
求助须知:如何正确求助?哪些是违规求助? 3229838
关于积分的说明 9787162
捐赠科研通 2940432
什么是DOI,文献DOI怎么找? 1611923
邀请新用户注册赠送积分活动 761063
科研通“疑难数据库(出版商)”最低求助积分说明 736488